US Stock MarketDetailed Quotes

OGEN Oragenics

Watchlist
  • 1.4000
  • +0.3200+29.63%
Close Aug 9 16:00 ET
  • 1.3200
  • -0.0800-5.71%
Post 20:01 ET
7.81MMarket Cap-190P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    103622690
    103622690
    Yesterday 00:04
    $Oragenics (OGEN.US)$ Oragenics, Inc. (NYSE American: OGEN) Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing -  Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced its lead candidate for treating concussion successfully completed a study that indicates ONP-002 does not cause cardiotoxicity. ONP-002 is a new chemical entity (NCE) designed to target the brain through del...
    103622690
    103622690
    Aug 8 14:31
    $Oragenics (OGEN.US)$ On Thursday, Oragenics Inc. (NYSE:OGEN) announced that its lead candidate for treating concussion completed a study that indicates ONP-002 does not cause cardiotoxicity.
    103622690
    103622690
    Aug 8 14:30
    $Oragenics (OGEN.US)$ Common causes of concussions include falls, motor vehicle accidents, and contact sports.
    According to the CDC, the total annual healthcare cost for nonfatal traumatic brain injuries (TBIs) exceeds $40.6 billion
    103622690
    103622690
    Aug 8 14:26
    $Oragenics (OGEN.US)$ Before conducting a clinical trial, the FDA requires pharmaceuticals to be tested on cardiac receptors to ensure that they do not show any causes of electrical malformations.Based on Phase 1 ONP-002 clinical trial dosing and subsequent blood plasma concentrations, ONP-002 is expected to have a large cardiac safety margin, suggesting that ONP-002 treatment for concussion will not cause cardiac arrhythmia (irregular heartbeat).
    103622690
    103622690
    Aug 8 14:24
    $Oragenics (OGEN.US)$ Concussion, a mild traumatic brain injury that affects brain function, is a significant unmet medical need, with an estimated 69 million cases reported annually worldwide
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%